CompletedN/Aketamine
Ketamine Infusion as Sedative Analgesic in Severe ARDS
Sponsored by Interfaith Medical Center
NCT ID
NCT04818827
Target Enrollment
124 participants
Start Date
2020-02-01
Est. Completion
2021-02-14
About This Study
To evaluate whether ketamine is a safe sedative-analgesic agent to be used in an intensive care unit (ICU) setting as compared to traditionally used agents such as propofol, opioids, and midazolam
Conditions Studied
Eligibility
Age:18 Years - 90 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 with an arterial partial pressure of oxygen divided by the inspired oxygen concentration (P/F) ratio \< 150 with a minimum 5 cm of positive end-expiratory pressure on a mechanical ventilator Exclusion Criteria: * post-cardiac arrest status, * premorbid diagnosis of dementia, * dependency on extra-corporeal therapies prior to or during ICU stay
Study Locations (1)
Interfaith Medical Center
New York, New York, United States